Skip to content
Blerp – Lifestyle
Author:
Medicenna Therapeutics Corp.
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
April 9, 2026
Medicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
March 18, 2026
←
Previous Page
1
2